In 2023, the sold production of chemical contraceptive preparations based on hormones or spermicides in Germany stood at an observable reference point against which future forecasts are compared. The forecasted values from 2024 to 2028 demonstrate a steady increase year-on-year. Specifically, growth rates are approximately consistent with a trend of slight progressive increases each year.
Key variations within this period show a positive forecast trend, suggesting a compounded annual growth rate (CAGR) over the five years, which underline a stable market inclination towards these contraceptives in Germany.
Future trends to watch for include potential shifts in consumer preferences towards alternative contraceptive methods, technological advancements in contraceptive development, and the impact of healthcare policies on market dynamics. Monitoring these elements can provide insights into sustained market growth or emerging challenges in the sector.
